Clinical Trials Browser

Unknown × Oxaliplatin × Dermatologic × Clear all

NCT00538005 2014-01-10

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Phase 1/2 Unknown

Melanoma